Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
08/2005
08/25/2005US20050187273 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
08/25/2005US20050187257 Methods of treating sepsis
08/25/2005US20050187238 Benzofuran derivatives, their production and use
08/25/2005US20050187111 (2-halo-4-ethylphenyl)acetic acids and esters and 2-(2-halo-4-ethylphenyl)-1,1,1-trichloroethanes, useful as intermediates for the preparation of phenyl-substituted cyclic ketoenol pesticides and herbicides
08/25/2005US20050187110 Novel herbicides
08/25/2005US20050183635 stability of gamma-quinacridone pigment during milling by addition of 2,9-dichloroquinacridone
08/25/2005CA2555815A1 Dihydrotetrabenazines and pharmaceutical compositions containing them
08/25/2005CA2555594A1 Pyridazinones as antagonists of a4 integrins
08/25/2005CA2555287A1 Heterocyclic gaba-a subtype selective receptor modulators
08/24/2005EP1566384A1 Novel azole derivatives
08/24/2005EP1566378A1 Isoindoline derivative
08/24/2005EP1565455A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
08/24/2005EP1343789B1 Tricyclic derivatives of indole with antiangiogenic activity
08/24/2005EP1334085B1 Sulfamides as gamma-secretase inhibitors
08/24/2005EP1244652B1 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity
08/24/2005CN1659640A Optical data carrier comprising a cationic aminoheterocyclic dye as light-absorbent compound in the information layer
08/24/2005CN1659170A Thienyl compounds
08/24/2005CN1659146A Process for the manufacture of quinoline derivatives
08/24/2005CN1659143A Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
08/24/2005CN1658847A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
08/24/2005CN1216057C Derivative of camptothecin kind analogue and its preparation method
08/24/2005CN1216056C Sulfamato hydroxamic acid metalloprotease inhibitor
08/24/2005CN1216051C Macrocyclic analogs and method of their use and preparation
08/23/2005US6933316 Indole compounds
08/23/2005US6933306 Anticancer agents; antiinflammatory agents; autoimmune disease
08/23/2005US6933302 Nitrogen-based homo-camptothecin derivatives
08/23/2005US6933261 2,4,5-Trisubstituted phenylketoenols
08/18/2005WO2005075978A2 Time-temperature indicator based on valence isomerizations
08/18/2005WO2005075600A1 Organic element for electroluminescent devices
08/18/2005WO2005056554A3 Azepinoindole derivatives as pharmaceutical agents
08/18/2005WO2004069197A3 Novel substituted 2,3-benzodiazepine derivatives
08/18/2005WO2004060890A8 2-oxopyridin-3-yl thia (di) azole derivates for use in the treatment of cell proliferation and apoptosis related diseases
08/18/2005US20050182109 Heteroaryl substituted spriocyclic sulfamides for inhibition of gamma secretase
08/18/2005US20050182093 Novel compounds
08/18/2005US20050182079 Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline
08/18/2005US20050182047 Treatment of demyelinating disorders
08/18/2005US20050182043 4-amino-6-cycloalkyloxy-7-substituted quinazolines; inhibition of signal transduction mediated by tyrosine kinases; antitumor agents, respiratory system and gastrointestinal disorders
08/17/2005EP1564212A1 Method and intermedia used to obtain derivatives of 1-(1h- benzimidazole-2-yl)-4-(2-aminopyrimidine)piperidine
08/17/2005EP1563839A1 A method of analgesia
08/17/2005EP1562956A2 Fused bicyclic nitrogen-containing heterocycles
08/17/2005EP1562955A1 Quinazoline derivatives as src tyrosine kinase inhibitors
08/17/2005EP1562954A1 Ccr1 antagonists for the treatment of i.a. demyelinating inflammatory disease
08/17/2005EP1562944A1 Pyrazoloquinolines with immunomodulating activity
08/17/2005EP1562928A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
08/17/2005EP1562903A2 Mucin synthesis inhibitors
08/17/2005EP1562593A2 Topoisomerase-targeting agents
08/17/2005EP1266887B1 Indenoindoline derivatives, their process of preparation and pharmaceutical compositions containing them
08/17/2005EP1254141B1 Camptothecin -beta-alanine esters with topoisomerase i inibhition
08/17/2005EP1196397B1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
08/17/2005EP1192164B1 Thieno- and furopyrimidine derivatives as a2a-receptor antagonists
08/17/2005EP0990650B1 Tricyclic pyrrole or pyrazole derivatives
08/17/2005CN1656109A Non nucleoside reverse transcriptase inhibitors
08/17/2005CN1656101A Esters in position 20 of camptothecins
08/17/2005CN1656100A Camptothecins with a modified lactone ring
08/17/2005CN1656096A Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders
08/17/2005CN1656081A 4-anilino quinazoline derivatives as antiproliferative agents
08/17/2005CN1656077A Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors
08/17/2005CN1655778A Method for the use of pyranoindole derivatives to treat infection with hepatitis C virus
08/17/2005CN1215067C 哒嗪酮醛糖还原酶抑制剂 Pyridazinone aldose reductase inhibitors
08/17/2005CN1215061C Process for preparing anticancer compound, and intermediate
08/17/2005CN1215060C Condensed pyrazole compound, composition containing it and its application
08/16/2005US6930117 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
08/16/2005US6930109 Antidepressant azaheterocyclyl methyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene
08/16/2005US6930107 treating obesity, overweight condition, hyperlipidemia, thyroid disease, hypothyroidism, thyroid cancer and related disorders
08/16/2005CA2342974C Methods and compositions for inhibition of angiogenesis
08/16/2005CA2166059C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
08/16/2005CA2106642C Carbazolone derivatives and process for preparing the same
08/11/2005WO2005073213A2 Method for the production of 3-amino-5-(hydroxymethyl)cyclopentane-1,2-diol derivatives
08/11/2005WO2005072066A2 Preventive or therapeutic agent for diabetic maculopathy
08/11/2005WO2005051302A3 Bicyclic inhibitors of mek and methods of use thereof
08/11/2005WO2005046588A3 Compounds, compositions, and methods
08/11/2005WO2004103276A3 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
08/11/2005US20050176810 Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof
08/11/2005US20050176801 Acyl bicyclic derivatives of pyrrol
08/11/2005US20050176786 Anticancer agents; inhibit Abelson tyrosine kinase, Ron receptor tyrosine kinase, Met receptor tyrosine kinase, Fms-like tyrosine kinase-3, or p21-activated kinase-4; e.g. 3-substituted-5-(carbonylamino or sulfonamido)-1H-pyrazolo[3,4-d]thiazole
08/11/2005US20050176764 Medicine for treating cancer
08/11/2005US20050176752 Such as 2,2,4-trimethyl-1,3-dioxolo[4,5-c]piperidin-7-ol; reacting methanesulfonic acid 6-hydroxy-2,2,6-trimethyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-ylmethyl ester with phthalimide; avoids the use of reagents such as corrosive triflic anhydride and toxic sodium azide; intermediates to antivirals
08/11/2005US20050176745 Based on spiro(1-azabicyclo[2.2.2]octane-3,2'(3'H)-furo[2,3-b]pyridine) ring; ligands for nicotinic acetylcholine receptors; Alzheimer's disease, cognitive or attention disorders, anxiety, depression, smoking cessation, neuroprotection, schizophrenia, analgesia, Tourette's and Parkinson's
08/11/2005US20050176730 Amide and urea derivatives as 5-HT reuptake inhibitors and as 5-HT 1B/1D ligands
08/11/2005US20050176706 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
08/11/2005US20050176699 Benzodiazepine derivatives, preparation thereof and use thereof
08/11/2005DE102004003812A1 Arylsubstituierte Heterozyklen, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel Aryl substituted heterocycles, processes for their preparation and their use as medicaments
08/11/2005CA2553084A1 Novel benzofuran derivative, medicinal composition containing the same, and uses of these
08/10/2005EP1561753A2 Benzo[b]chromenonapthyridin-7-one and pyrano[2',3':7,8]quino[2,3-b]Quinoxalin-7-one derivatives, process of synthesis, pharmaceutical compositions and their antitumoral properties for the treatment of cancer
08/10/2005EP1560947A1 Process for electrochemical oxidation of ferrocyanide to ferricyanide
08/10/2005EP1560835A1 Spirocyclic cyclohexane derivatives
08/10/2005EP1560834A1 New tricyclic derivatives as ltd4 antagonists
08/10/2005EP1560831A1 Novel amino-substituted dihydropyrimido [4,5-d] pyrimidin one derivatives, their manufacture and use as pharmaceutical agents
08/10/2005EP1560584A2 Fab i inhibitors
08/10/2005EP0876373B1 Method for preparing camptothecin derivatives
08/10/2005CN1653531A Optical storage media comprising pentacyclic xanthylium dyes
08/10/2005CN1653069A R-enantiomers of pyranoindole derivatives and the use thereof for the treatment of hepatitis C virus infection or disease
08/10/2005CN1653059A Macrocyclic compounds useful as pharmaceuticals
08/10/2005CN1651435A Method of preparing fugutoxin water extract
08/10/2005CN1651434A Preparation method of 6-cyano-7-methyl-1, 1-(2, 2-dimethyl-1, 3-propylidine dioxy)-5-oxo-1, 2, 3, 5-tetrahydro indolidin (I)
08/10/2005CN1651433A Salviolic acid berberine double salt, its preparation method and application
08/10/2005CN1651432A Method of refining plamatine from herba fibranreae recisae total ulkuloid and its application
08/10/2005CN1651392A 2-and 2, 5-substituted phenylketoenols
08/10/2005CN1214030C Prodrugs of imidazopyridine derivatives, medine containing same and use
08/09/2005US6927295 1-alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators